Copegus
$ 171,00 – $ 452,00Price range: $ 171,00 through $ 452,00
Coreg
$ 41,00 – $ 651,00Price range: $ 41,00 through $ 651,00
Cordarone
$ 40,00 – $ 720,00Price range: $ 40,00 through $ 720,00
Cordarone is a highly effective anti-arrhythmic medication designed to restore and maintain a steady heart rhythm. It is primarily used to treat serious, life-threatening ventricular arrhythmias such as recurrent ventricular fibrillation and unstable ventricular tachycardia. The active ingredient works by stabilizing electrical activity in the heart and relaxing overactive cardiac muscles. This medication is particularly beneficial for patients who have not responded well to other types of heart rhythm treatments. By regulating the heartbeat, Cordarone helps improve cardiac efficiency and supports long-term cardiovascular health.
Active substance: Amiodarone
SKU:
Cordarone
Category: Heart Disease
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Cordarone should only be administered under close medical supervision due to its complex pharmacological profile and risk of severe, potentially life-threatening toxicities. This prescription antiarrhythmic medication is reserved for managing documented, recurrent ventricular arrhythmias that do not respond to other available therapies. Because of its lingering distribution in body tissues, initiating treatment typically requires inpatient cardiac monitoring and individualized dose titration.
As an oral formulation containing amiodarone hydrochloride, Cordarone acts as a Class III antiarrhythmic agent with multi-channel blocking actions. Patients prescribed this therapy require regular follow-up assessments, including baseline and periodic pulmonary function tests, liver enzyme panels, and ophthalmic examinations to detect early signs of cumulative toxicity.
Clinical Overview and Pharmacologic Profile
Main uses
Cordarone (amiodarone hydrochloride) is an FDA-approved prescription drug indicated for the treatment of life-threatening recurrent ventricular arrhythmias, specifically recurrent ventricular fibrillation and hemodynamically unstable ventricular tachycardia. Due to the substantial risk of pulmonary, hepatic, and cardiac toxicity, healthcare providers restrict its use to patients who are intolerant of or refractory to alternative antiarrhythmic agents.
In clinical practice, cardiologists may sometimes utilize Cordarone for off-label indications, such as maintenance of sinus rhythm in severe atrial fibrillation or heart rate control in patients with structural heart disease when conventional beta-blockers or calcium channel blockers are contraindicated. Any off-label application must be strictly supervised by a physician, carefully balancing clinical necessity against the drug’s long-term organ toxicity profile.
How the drug works
Cordarone is categorized as a Class III antiarrhythmic, but it exhibits electrophysiological characteristics across all four Vaughan Williams classification categories. Its primary therapeutic mechanism involves blocking voltage-gated potassium channels, which prolongs the cardiac action potential duration and extends the effective refractory period in both atrial and ventricular cardiac tissue. This stabilization prevents re-entrant circuits that trigger dangerous electrical disturbances in the heart.
In addition to potassium channel blockade, Cordarone blocks inactivated sodium channels (Class I effect), exerts non-competitive alpha- and beta-adrenergic inhibition (Class II effect), and slows L-type calcium currents (Class IV effect). Warning: these combined actions decrease sinoatrial node automaticity and conduction velocity through the atrioventricular node, requiring constant clinical monitoring for excessive bradycardia or heart block.
What happens in the body
Following oral administration, Cordarone exhibits slow and variable absorption, with systemic bioavailability ranging from approximately 22% to 86%. The active ingredient, amiodarone hydrochloride, is highly lipophilic and extensively distributed into body fat, liver, lungs, skeletal muscle, and skin tissue, resulting in an extraordinarily large volume of distribution.
Cordarone undergoes extensive hepatic metabolism, primarily mediated by cytochrome P450 enzymes CYP3A4 and CYP2C8, forming the active metabolite desethylamiodarone. Elimination is exceptionally prolonged compared to most oral medications; the elimination half-life ranges from 15 to 142 days (with a mean average of approximately 58 days). Consequently, therapeutic effects and potential adverse reactions may persist for months after treatment is discontinued.
Dosing Guidelines and Safety Monitoring
Dosing schedule
Dosing of Cordarone must be individualised and closely supervised by a prescribing specialist. For ventricular arrhythmias, therapy typically begins with an oral loading schedule–often ranging from 800 mg to 1600 mg daily in divided doses–administered for one to two weeks in a hospital setting until initial arrhythmia control is achieved. Warning: Never adjust or skip doses without explicit instructions from your cardiologist.
Following the initial loading phase, the dosage is gradually tapered down to 600 mg to 800 mg daily for approximately one month, before reducing to the lowest effective maintenance dose, typically 200 mg to 400 mg daily. Taking Cordarone consistently with respect to meals is important, as food significantly increases the rate and extent of amiodarone absorption.
First days of treatment
During the initial phase of treatment, patients are monitored in an inpatient facility in cities like Houston to track cardiac rhythm, blood pressure, and tolerance. Because Cordarone accumulates gradually in tissue, full antiarrhythmic effectiveness may take several days to several weeks to manifest fully.
Patients should expect daily electrocardiograms (ECGs) during loading to monitor the QTc interval and heart rate. Mild gastrointestinal discomfort, such as nausea or loss of appetite, can occur early on; taking the medication with meals helps minimize these initial digestive side effects.
Adverse reactions
Cordarone carries significant risk of adverse effects affecting multiple organ systems due to tissue accumulation and its iodine-rich chemical structure. Common reactions include corneal microdeposits (occurring in over 90% of adults on long-term therapy, visible during eye exams), photosensitivity (increased sun sensitivity leading to skin rash or blue-gray skin discoloration), and gastrointestinal symptoms like nausea, vomiting, or constipation.
More severe adverse reactions include pulmonary toxicity (interstitial pneumonitis or alveolitis), elevated serum transaminases indicating liver injury, thyroid dysfunction (hypothyroidism or hyperthyroidism, as amiodarone contains approximately 37% iodine by weight), and worsening of existing heart arrhythmias (proarrhythmia or severe bradycardia).
Red flags
Warning: Certain symptoms require immediate emergency medical intervention. Seek immediate emergency medical attention if you experience any of the warning signs detailed in the table below.
| Emergency Sign | Potential Underlying Toxicity | Action Required |
|---|---|---|
| New or worsening shortness of breath, cough, or chest pain | Pulmonary toxicity (pneumonitis / fibrosis) | Seek emergency medical care immediately |
| Yellowing of skin or eyes (jaundice), dark urine, severe abdominal pain | Hepatic damage / liver toxicity | Contact provider or emergency services immediately |
| Severe dizziness, fainting, extremely slow heart rate (<50 bpm) | Symptomatic bradycardia or heart block | Seek immediate emergency cardiac care |
| Sudden vision changes, painful light sensitivity, blurred vision | Optic neuropathy or corneal injury | Seek immediate ophthalmic and medical evaluation |
| Swelling of face, lips, tongue, or difficulty swallowing | Severe allergic reaction (anaphylaxis) | Call 911 or go to the nearest emergency room |
Compatibility with other medicines
Cordarone interacts with a vast array of prescription and over-the-counter medications due to its inhibition of cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP2D6) and P-glycoprotein (P-gp). Never combine Cordarone with other drugs without explicit clearance from your pharmacist or prescriber.
- Warfarin: Cordarone significantly increases blood-thinning effects, raising bleeding risks. Warfarin dosages usually must be decreased by 33% to 50% when starting Cordarone.
- Digoxin: Concomitant use can double serum digoxin concentrations, risking severe digoxin toxicity. Digoxin doses should typically be reduced by half.
- Statins (e.g., Simvastatin): High doses of simvastatin combined with Cordarone increase the risk of severe muscle breakdown (rhabdomyolysis). Simvastatin doses should not exceed 20 mg daily.
- Other Antiarrhythmics & QTc-prolonging drugs: Combining with quinidine, sotalol, fluoroquinolones, or macrolide antibiotics significantly elevates the risk of fatal Torsades de Pointes ventricular arrhythmias.
- Grapefruit Juice: Warning: Never consume grapefruit juice while taking Cordarone, as it inhibits intestinal CYP3A4 and significantly increases blood levels of amiodarone.
Important precautions
Boxed Warnings issued by the FDA emphasize that Cordarone is intended only for life-threatening arrhythmias due to risk of fatal toxicity. Baseline chest X-rays, pulmonary function testing (including DLCO), baseline liver enzyme tests, and thyroid function panels (TSH, free T4, free T3) are mandatory prior to starting treatment and must be repeated every six months during maintenance therapy.
Special populations require altered management strategies:
- Pregnancy: Cordarone is classified as FDA Pregnancy Category D. It crosses the placenta and can cause fetal congenital goiter, thyroid dysfunction, and neurodevelopmental abnormalities. Use during pregnancy is restricted strictly to situations where benefit outweighs grave fetal risk.
- Breastfeeding: Amiodarone and its active metabolite pass into human breast milk in significant quantities. Nursing mothers must discontinue breastfeeding while on Cordarone therapy.
- Elderly Patients: Older adults may exhibit higher sensitivity to thyroid and cardiac adverse effects. Dosage selection should be conservative, usually starting at the lower end of the dosing range.
- Pediatric Use: Safety and effectiveness in pediatric patients have not been established in controlled clinical trials.
Day-to-day use
When taking Cordarone daily, establish a consistent routine. Take your prescribed dose at the same time every day, consistently either with meals or without meals, to maintain stable plasma levels. Wear protective clothing, sunglasses, and high-SPF sunscreen outdoors, as Cordarone causes marked photosensitivity that can lead to severe sunburn or permanent blue-gray skin pigmentation on sun-exposed areas.
Keep a detailed medical diary tracking your pulse rate daily. Inform all healthcare providers–including dentists, surgeons, and specialists–that you take Cordarone, as it can interact with anesthetic agents and blood thinners during procedures.
Storage and expiration
Store Cordarone tablets at room temperature between 68°F to 77°F (20°C to 25°C), with permitted excursions between 59°F to 86°F (15°C to 30°C). Keep the medication inside its original light-resistant container to protect it from light and moisture. Keep out of reach of children and pets. Do not use tablets past the expiration date stamped on the packaging.
Key Overview
| Property | Details |
|---|---|
| Active Ingredient | Amiodarone hydrochloride |
| Therapeutic Class | Class III Antiarrhythmic Agent |
| Dosage Form | Oral tablets (200 mg) |
| Route of Administration | Oral |
| Prescription Status | Prescription only (Rx) |
| Primary Purpose | Management of life-threatening recurrent ventricular arrhythmias |
| Elimination Half-Life | Averaging 58 days (range: 15 to 142 days) |
| Storage Requirements | Protect from light, store at 68°F to 77°F (20°C to 25°C) |
Common questions
What should I do if I miss a dose of Cordarone?
If you miss a dose, skip the missed tablet entirely and return to your regular dosing schedule the next day. Never double the dose to make up for a missed tablet. Because Cordarone stays in body tissues for a very long period, missing a single dose will not immediately lower blood levels, but consistent daily adherence is critical for cardiac stability.
Can I drink alcohol while taking Cordarone?
You should severely restrict or avoid alcohol consumption while taking Cordarone. Both alcohol and amiodarone are processed by the liver, and combining them increases the potential for hepatic inflammation or liver toxicity. Additionally, alcohol can trigger cardiac arrhythmias in sensitive individuals.
Why do I need regular eye exams while taking this medicine?
Cordarone causes microscopic yellow-brown deposits to form on the cornea in almost all patients treated for longer than six months. While corneal deposits usually do not affect vision, rarely Cordarone causes optic neuropathy or optic neuritis, which can lead to permanent visual impairment. Routine ophthalmic exams ensure early detection of optic nerve inflammation.
Is it safe to drive while taking Cordarone?
Caution is advised when driving or operating machinery upon starting Cordarone. The drug can cause dizziness, fatigue, halo vision, or blurred vision. Do not drive until you know how Cordarone affects your alertness and visual acuity.
How long does Cordarone stay in my system after stopping treatment?
Because of its extreme lipophilicity and long terminal elimination half-life (average of 58 days), complete clearance of amiodarone from body tissues can take anywhere from several months to up to a year after discontinuing the drug. Drug interactions and potential side effects may continue long after therapy ceases.
Always consult your healthcare provider before starting or changing any treatment.
In accordance with FDA requirements.
Additional information
| Dosage |
100mg ,200mg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Accupril
$ 68,00 – $ 256,00Price range: $ 68,00 through $ 256,00
Active substance: Hypertension
More Details
This product has multiple variants. The options may be chosen on the product page
Aggrenox
$ 50,00 – $ 288,00Price range: $ 50,00 through $ 288,00
Active substance: Dipyridamole
More Details
This product has multiple variants. The options may be chosen on the product page
Aldactone
$ 33,00 – $ 345,00Price range: $ 33,00 through $ 345,00
Active substance: Spironolactone
More Details
This product has multiple variants. The options may be chosen on the product page
Atorlip 10
$ 55,00 – $ 264,00Price range: $ 55,00 through $ 264,00
Active substance: Atorvastatin
More Details
This product has multiple variants. The options may be chosen on the product page
Atorlip 5
$ 43,00 – $ 157,00Price range: $ 43,00 through $ 157,00
Active substance: Atorvastatin
More Details
This product has multiple variants. The options may be chosen on the product page
Betapace
$ 9,00 – $ 260,00Price range: $ 9,00 through $ 260,00
Active substance: Sotalol
More Details
This product has multiple variants. The options may be chosen on the product page
Bystolic
$ 38,00 – $ 275,00Price range: $ 38,00 through $ 275,00
Active substance: Nebivolol
More Details
This product has multiple variants. The options may be chosen on the product page
Lonitab
$ 224,00 – $ 561,00Price range: $ 224,00 through $ 561,00
More Details
This product has multiple variants. The options may be chosen on the product page
